Effects of Physical Training on Health Markers of Post-bariatric Patients (Obesity)

April 14, 2024 updated by: Luiz Guilherme Kraemer-Aguiar, MD, Rio de Janeiro State University

Effects of Physical Training on Physical and Functional Fitness, Physical Activity Level, Endothelial Function, Hemodynamic Variables, Bone Metabolism and Quality of Life of Post-bariatric Patients: a Randomized Controlled Trial

The purpose of this clinical trial is to study the effects of resistance training program on physical-functional fitness, muscle mass and strength, endothelial function, blood pressure, biochemical markers of cardiovascular risk and bone metabolism, density and microstructure and quality of life of post-bariatric patients (Study 1). To compare the bone and muscle changes in post-bariatric patients by Roux-en-Y Gastric Bypass Surgery with non-bariatric controls, as well as to correlate these health indicators with surgery time and weight loss (Study 2).

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Randomized controlled trial (Study 1) will feature post-bariatric patients in outpatient care at the public health unit. The post-bariatric patients will be randomized through a random code generator software (www.randomization.com) at a ratio of 1:1, into two groups: a) Intervention group - that will perform a supervised RT program for 6-months or b) Non-exercised control group - that will receive the standard clinical follow-up and shall not change their physical activity behavior. The exercise sessions will include: a) 10-min specific warm-up, consisting of one set of 20 repetitions with loads corresponding to 50% of the resistance used in the first exercise of the training session; b) 45-min of resistance exercises for the upper and lower body (8 single and multi-joint exercises with free weights and machines, including seated rowing, leg press, bench press, leg flexion, pull down, leg extension, shoulder press, and abdominal exercises), performed with 2-3 sets of 8 to 12 repetitions with loads ≥ 70% of one-repetition maximum (1RM) interspersed with 2 min intervals between sets; c) 5-min recovery with stretch and cool-down exercises. During six months, all training sessions will occur three times a week on nonconsecutive days. The outcomes will be assessed by dual energy X-ray emission densitometry (DXA); high resolution peripheral quantitative computed tomography (HR-pQCT), repetition maximum, handgrip strength; biochemical analysis (blood lipid profile, blood glucose and biomarkers of bone formation and absorption and calcium metabolism); venous occlusion plethysmography and nailfold videocapillaroscopy; blood pressure measurement and 36-Item Short-form Health Survey. The cross-sectional study (Study 2) will have 2 groups: post-bariatric patients group (BG) and control group (CG) - non-bariatric controls. Outcomes will be assessed by DXA; HR-pQCT; handgrip strength and biochemical analysis (blood lipid profile, blood glucose and biomarkers of bone formation and absorption and calcium metabolism).

Study Type

Interventional

Enrollment (Actual)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Rio De Janeiro, Brazil
      • Rio De Janeiro, Rio De Janeiro, Brazil, Brazil, 20550013
        • Laboratory for Clinical and Experimental Research on Vascular Biology, Rio de Janeiro State University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 50 years (Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients subjected to Roux-en-Y gastric bypass
  • Aging 18 to 50-years
  • At least 12 months from surgery

Exclusion criteria:

  • Smoking
  • Alcoholism
  • Gestation
  • Cardiovascular disease
  • Respiratory disease
  • Neurological disease
  • Infectious disease
  • Endocrine disease
  • Musculoskeletal impairments
  • Use of hormonal replacement therapy that influence bone metabolism
  • Use of medications that influence bone metabolism
  • Start some physical exercise program during the study
  • Excess weight loss <50%
  • Use drugs that interfere with weight
  • Revisional bariatric surgery
  • Regular physical exercise

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Exercise training
Post-bariatric patients - Intervention group
Resistance training program performed during 6 months, 3 sessions per week
No Intervention: No intervention
Post-bariatric patients - Non-exercised control group

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes from baseline body composition at 6 months
Time Frame: Baseline and 6 months of follow-up
Muscle mass and body mineral density will be assessed by Dual-energy X-ray Absortiometry
Baseline and 6 months of follow-up
Changes from baseline bone microarchitecture at 6 months
Time Frame: Baseline and 6 months of follow-up
Bone microarchitecture will be assessed by High-resolution peripheral quantitative computed tomography
Baseline and 6 months of follow-up
Changes from baseline muscle strength at 6 months
Time Frame: Baseline and 6 months of follow-up
Muscle strength will be evaluated by one repetition maximum test and handgrip strength
Baseline and 6 months of follow-up
Changes from baseline blood biomarkers at 6 months
Time Frame: Baseline and 6 months of follow-up
Bone formation and reabsorption biomarkers will be evaluated by blood sample collection
Baseline and 6 months of follow-up
Changes from baseline blood biomarkers at 6 months
Time Frame: Baseline and 6 months of follow-up
Metabolic profile will be evaluated by blood sample collection
Baseline and 6 months of follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes from baseline quality of life indicators at 6 months
Time Frame: Baseline and 6 months of follow-up
Quality of life indicators will be evaluated by 36-Item Short-form Health Survey
Baseline and 6 months of follow-up
Changes from baseline cardiovascular risk factors at 6 months
Time Frame: Baseline and 6 months of follow-up
Cardiovascular risk factors will be evaluated by body mass index, waist circumference, blood pressure, triglycerides, HDL-c, LDL-c, total cholesterol, and fasting glycemia
Baseline and 6 months of follow-up
Changes from baseline anthropometric markers at 6 months
Time Frame: Baseline and 6 months of follow-up
Anthropometric markers will be determined by a digital scale and wall-mounted stadiometer
Baseline and 6 months of follow-up
Changes from baseline hemodynamic measurement at 6 months
Time Frame: Baseline and 6 months of follow-up
Blood pressure and heart rate will be assessed by a digital sphygmomanometer
Baseline and 6 months of follow-up
Changes from baseline endothelial function at 6 months
Time Frame: Baseline and 6 months of follow-up
Endothelial function will be evaluated by venous occlusion plethysmography and periungual videocapilaroscopy
Baseline and 6 months of follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Luiz Guilherme K De Aguiar, PhD, Rio de Janeiro State University, Rio de Janeiro, RJ, Brazil

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2022

Primary Completion (Actual)

December 31, 2023

Study Completion (Actual)

March 31, 2024

Study Registration Dates

First Submitted

December 4, 2019

First Submitted That Met QC Criteria

December 7, 2019

First Posted (Actual)

December 10, 2019

Study Record Updates

Last Update Posted (Actual)

April 16, 2024

Last Update Submitted That Met QC Criteria

April 14, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Bariatric Surgery

Clinical Trials on Exercise training

3
Subscribe